Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Lung Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Lung Cancer
    Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
    NICE Issues Final Guidance on the Use of Erlotinib for the Treatment of NSCLC - (DGNews)
    TopAbstracts in Lung Cancer 11/26/2008 - (DGNews)
    Oral Gefitinib as Effective as Injected Docetaxel for Survival of Patients With NSCLC - (DGNews)
    TopAbstracts in Lung Cancer 11/12/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Lung Cancer
    • Latest Data From Chicago Provide New Insight Into the Evolving Role of Cytotoxic and Targeted Therapies in Early-Stage NSCLC
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
    • Silica-Related Lung Disease: It's Still Here

      Webcasts/CME archive

       Recent cases - Lung Cancer
        A Resected Case of Solitary Pancreatic Metastasis from Adenocarcinoma of the Lung
        Diverse Histologic Appearances in Pulmonary Mucinous Cystic Neoplasia: A Case Report
        Extrapulmonary Small Cell Sarcinoma: Involvement of the Brain Without Evidence of Extracranial Malignancy by Serial PET/CT Scans
        Neurocognitive Deficits in a Patient with Small Cell Lung Cancer: A Case Report
        Hypertrophic Pulmonary Osteoarthropathy Secondary to Bronchial Adenocarcinoma and Coexisting Pulmonary Tuberculosis: A Case Report

        Cases archive
          




        my personal edition > lung cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Lifetime Second-hand Smoke Exposure Impacts NSCLC Survival: Presented at AACR

        By Charlene Laino

        WASHINGTON, D.C. -- April 6, 2006 -- Early-stage non-small cell lung cancer (NSCLC) patients who are exposed to high levels of second-hand smoke over their lifetimes do not live as long, on average, as those with low levels of exposure, a new study suggests.

        "We know that second-hand smoking increases the risk of lung cancer, and studies have suggested that it is associated with lung cancer mortality," said lead author Wei Zhou, MD, PhD, Research Scientist, Harvard School of Public Health, Boston, Massachusetts, United States.

        "But this is the first study to show that second-hand smoking also is associated with lung cancer survival," Dr. Zhou reported here on April 4th at the 97th Annual Meeting of the American Association for Cancer Research (AACR).

        The researchers examined the association between passive smoke exposure and overall survival in 393 patients with early-stage NSCLC who underwent surgical resection. Additionally, 32 (8%) patients received post-operative radiation and 5 (1%) patients received adjuvant chemotherapy.

        The mean age of patients was 69 years and 49% of them were women. Eight percent had never smoked, 57% were former smokers, and 35% still smoked.

        Nearly half suffered from adenocarcinoma, 28% had squamous cell carcinoma, 5% had large cell carcinoma, and 13% had bronchioloalveolar carcinoma. Fifty-three percent were Stage IA, 29% were Stage IB, and 18%, Stage IIA/IIB.

        The researchers collected information on exposure to passive smoke at work, home, and leisure-time locations, such as restaurants. The questionnaire, administered by an interviewer, asked about length of exposure at each location over the patient's lifetime, before the diagnosis of lung cancer.

        At a median follow-up of 66 months, 135 patients had relapsed and 213 had died.

        Results showed that the overall 5-year survival rate decreased with increasing exposure: 71% of patients in the lowest quartile of exposure -- corresponding to less than 28 years on average -- were alive at 5 years, compared with 61% in the next highest quartile, and 49% in the third highest. In the highest quartile -- corresponding to more than 48 years of exposure -- 47% survived 5 years (P <.001, logrank test).

        After adjustment for age, gender, stage of cancer, and the patients' own cigarette smoking over their lifetimes, those in the highest quartile for second-hand smoke exposure were 57% more likely to die than those in the lowest quartile (P trend =. 04).
        .
        Workplace exposure appeared to be the most important factor. A statistically significant association was found for such exposures (adjusted hazards ratio [AHR], 1.71, 95% confidence interval [CI], 1.12-2.61), but not for exposure at home (AHR, 1.26, 95% CI, 0.86-1.86) or at leisure-time locations (AHR, 1.28; 95% CI, 0.83-1.95).

        "The reason for the strong association with workplace exposure may be due both to the length of time people spend at work and the higher levels of smoke they could be exposed to there," Dr. Zhou said.

        The researchers now plan to look at survival differences among lung cancer patients who are exposed to second-hand smoke after their diagnosis and at the genetic factors associated with second-hand smoking, smoking, and survival, he said.


        [Presentation title: Second Hand Smoke Exposure and Survival in Early Stage Non-Small Cell Lung Cancer Patients. Abstract LB-345]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send